⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session

Published 17/01/2024, 10:32
© Reuters.  Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
PRGS
-
NTRA
-
RGNX
-
PI
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday.

Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as the company posted stronger-than-expected results for its fourth quarter.

The company said it sees FY24 adjusted earnings of $4.58 to $4.68 per share on revenue of $722 million to $732 million.

Progress Software shares gained 2.9% to $55.14 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

  • Natera, Inc. (NASDAQ: NTRA) jumped 8.3% to $68.10 in pre-market trading. Natera announced that jury in US District Court for W. District of Texas ruled in patent infringement lawsuit brought by Ravgen, awarding $57 million in damages, below the $410 million sought.
  • Impinj, Inc. (NASDAQ: PI) surged 7.6% to $88.01 in pre-market trading after the company reported preliminary revenue and adjusted EBITDA for the fourth quarter.
  • REGENXBIO Inc. (NASDAQ: RGNX) shares gained 4.9% to $16.02 in pre-market trading. REGENXBIO announced interim data from Phase II AAVIATE trial of ABBV-RGX-314 for the treatment of wet AMD using suprachoroidal delivery.
  • Rumble Inc. (NASDAQ: RUM) gained 4.8% to $4.11 in pre-market trading after jumping over 15% on Tuesday.
  • Maplebear Inc. (NASDAQ: CART) rose 2.6% to $24.50 in pre-market trading.

Now Read This: Investor Sentiment Eases Further As Treasury Yields Edge Higher; Dow Tumbles Over 200 Points

Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.